课题基金 / 基金详情

Career Development in Pediatric and Medical Oncology

Career Development in Pediatric and Medical Oncology
儿科和肿瘤内科的职业发展
批准号:
10693405
负责人:
NANCY ELLEN DAVIDSON
金额:
$56.73万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
未结题
起止时间:
1997-09-30 至 2026-08-31

项目摘要

项目成果

NANCY ELLEN DAVIDSON的其他基金

相似基金

相关文献

中文摘要
翻译
项目总结/文摘
英文摘要
PROJECT SUMMARY/ABSTRACT We are requesting funds for The Paul Calabresi Career Development Award for Clinical Oncology in Pediatric and Medical Hematology/Oncology at the Fred Hutchinson Cancer Research Center, University of Washington School of Medicine and Seattle Children’s Hospital. The Career Development Program will interface with our Pediatric Hematology/Oncology, Medical Oncology, and adult Hematology Training Programs at the Fred Hutchinson Cancer Research Center and the Departments of Pediatrics and Medicine at the University of Washington, with the goal of developing and supporting transition of clinical translational investigators into independent investigators. This K12 Career Development Award for Clinical Oncology will be an integral part of our program towards grooming the next generation of independent clinical researchers by supporting four physicians each year who have completed fellowship training in the pediatric or medical hematology/oncology training programs with track record of promising independent clinical/translational careers. Prior to entry into the program, scholar candidates will have acquired clinical skills and basic laboratory tools of modern biology and translation of laboratory findings to clinical application. Those most qualified and motivated to enter into investigative endeavors in clinical translational research will be selected. The K12 scholars will receive two to three years of funding to help develop requisite experience to conduct clinical translational research, translate their findings to patients, and generate sufficient data to help establish independent research careers. The aim of their projects will be to contribute new and useful information relevant to clinical oncology and to develop the clinical research capabilities of the trainees. The supported research projects include those in the areas of hematopoietic stem cell transplantation, immunology and immunotherapy, transplantation biology, outcome and quality of life research, malignant hematopoiesis, human immunogenetics, and programs in solid tumor research including tumors of the brain, breast, ovaries, prostate, and breast. Additional projects in molecular biology and gene therapy, as well as other relevant research arenas, will be available. Trainees will also gain experience in clinical protocol development, conduct, and evaluation, and will receive didactic training in biostatistics, clinical trial design and biomedical research integrity. This program utilizes the laboratory and clinical research facilities of the Fred Hutchinson Cancer Research Center, the University of Washington, and the Seattle Children’s Hospital Research Institute, and the clinical facilities of the Seattle Cancer Care Alliance, The University of Washington, and the Seattle Children’s Hospital.
期刊论文(43)
专著(0)
科研奖励(0)
会议论文
DOI: 10.3390/cancers14122934
发表时间: 2022-06-14
期刊: Cancers
影响因子: 5.2
作者: [Godwin CD, Rodríguez-Arbolí E, Othus M, Halpern AB, Appelbaum JS, Percival MM, Hendrie PC, Oehler VG, Keel SB, Abkowitz JL, Cooper JP, Cassaday RD, Estey EH, Walter RB]
通讯作者: Walter RB
The immunogenicity of a new human minor histocompatibility antigen results from differential antigen processing.
新的人类小型组织相容性抗原的免疫原性是由差异抗原加工引起的。
DOI: 10.1084/jem.193.2.195
发表时间: 2001-01-15
期刊: JOURNAL OF EXPERIMENTAL MEDICINE
影响因子: 15.3
作者: [Brickner, A G, Warren, E H, Caldwell, J A, Akatsuka, Y, Golovina, T N, Zarling, A L, Shabanowitz, J, Eisenlohr, L C, Hunt, D F, Engelhard, V H, Riddell, S R]
通讯作者: Riddell, S R
Quantitative, real-time polymerase chain reactions for FLT3 internal tandem duplications are highly sensitive and specific.
FLT3 内部串联重复的定量、实时聚合酶链反应具有高度敏感性和特异性。
DOI: 10.1016/s0145-2126(01)00087-x
发表时间: 2001
期刊: Leukemia research
影响因子: 2.7
作者: [Stirewalt,DL, Willman,CL, Radich,JP]
通讯作者: Radich,JP
DOI: 10.1136/jitc-2020-001591
发表时间: 2020-12
期刊: Journal for immunotherapy of cancer
影响因子: 10.9
作者: [Veatch JR, Singhi N, Jesernig B, Paulson KG, Zalevsky J, Iaccucci E, Tykodi SS, Riddell SR]
通讯作者: Riddell SR
13
    Clinical Investigator Team Leadership Award
    Continuing Umbrella Research Experiences
    Clinical Trial Reporting Program
    SENIOR LEADERSHIP
    国内基金
    海外基金
    层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
    • 批准号:
      2021JJ40433
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2021
    • 负责人:
      孙磊
    • 依托单位:
    寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
    • 批准号:
      32001603
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      24.0万元
    • 批准年份:
      2020
    • 负责人:
      段真珍
    • 依托单位:
    AREA国际经济模型的移植.改进和应用
    • 批准号:
      18870435
    • 项目类别:
      面上项目
    • 资助金额:
      2.0万元
    • 批准年份:
      1988
    • 负责人:
      史树中
    • 依托单位: